Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.79954 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.74276 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.74666 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.68485 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.68475 | 32 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.80121 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.75048 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.72141 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.71269 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.72051 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.72925 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.71561 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.73936 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.73419 | 33 |